Cardiovascular Protective Effects of NP-6A4, a Drug with the FDA Designation for Pediatric Cardiomyopathy, in Female Rats with Obesity and Pre-Diabetes is a research paper published in Cells (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
NIH NHLBI
Grant: R01HL138988-01A1
NIH NHLBI
Grant: K99/R00HL121152
NIH NHLBI
Grant: 932792
NHLBI NIH HHS
Grant: K99 HL121152
NIH HHS
Grant: R01HL138988-01A1 (LP)
NHLBI NIH HHS
Grant: R00 HL121152
NHLBI NIH HHS
Grant: R01 HL138988
National Institutes of Health
Grant: 3R01HL138988-02S1
Mechanisms for Sex Differences in CVD Pathology and Development of a Targeted Therapeutic
National Institutes of Health
Grant: 5R00HL121152-05
Multiplexed Molecular Imaging of Cell Death Pathways
MeSH Terms
Keywords